Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB

• Katherine A. Abrahams ,

  Contributed equally to this work with: Katherine A. Abrahams, Jonathan A. G. Cox

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

  ⨯
• Jonathan A. G. Cox ,

  Contributed equally to this work with: Katherine A. Abrahams, Jonathan A. G. Cox

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

  ⨯
• Vickey L. Spivey,

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

  ⨯
• Nicholas J. Loman,

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

  ⨯
• Mark J. Pallen,

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

  ⨯
• Chrystala Constantinidou,

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

  ⨯
• Raquel Fernández,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Carlos Alemparte,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Modesto J. Remuiñán,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• David Barros,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Lluis Ballell ,

  * E-mail: g.besra@bham.ac.uk (GSB); Lluis.p.ballell@gsk.com (LB)

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Gurdyal S. Besra

  * E-mail: g.besra@bham.ac.uk (GSB); Lluis.p.ballell@gsk.com (LB)

  Affiliation School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom

  ⨯